AZPET

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAZPET
Drug Alias NameFluoro-18-RS-86molecular imaging agents (Massachusetts General Hospital/FluoroPharma)18F-RS-86RS-86-[18F]AZPET
ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentSmall molecules +[4] 
Mechanisms of ActionMuscarinic acetylcholine receptor agonistsBeta amyloid A4 protein aggregation inhibitorsPositron-emission tomography enhancers
TargetsBeta amyloid A4 proteinMuscarinic acetylcholine receptor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe General Hospital Corporation D/B/A Massachusetts General Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe General Hospital Corporation D/B/A Massachusetts General HospitalFluoropharma Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A